Literature DB >> 19236564

Drooling.

Crispian Scully1, Jacobo Limeres, Michael Gleeson, Inmaculada Tomás, Pedro Diz.   

Abstract

INTRODUCTION: Drooling is the overflowing of saliva from the mouth. It is mainly due to neurological disturbance and less frequently to hypersalivation. Drooling can lead to functional and clinical consequences for patients, families, and caregivers. The aim of this review is to emphasize the clinical aspects of the assessing and management of drooling.
METHODS: All papers and clinical reviews of drooling in the electronic data bases (Medline, PubMed, Embase and the Cochrane Library) for the past 40 years in any languages have been evaluated.
RESULTS: The severity of drooling and the effects on the quality of life of the patient and family, help to establish a prognosis and to decide the therapeutic regimen. Treatment options range from conservative therapy to medication, radiation, or surgery, and often a combination is needed.
CONCLUSIONS: Chronic drooling remains a problem that can be difficult to manage. Despite the acceptable results obtained with most of the treatments, none is free of undesirable effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19236564     DOI: 10.1111/j.1600-0714.2008.00727.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  11 in total

Review 1.  Use of botulinum toxin in the neurology clinic.

Authors:  Erle C H Lim; Raymond C S Seet
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

2.  Management of drooling in disabled patients with scopolamine patches.

Authors:  Abigail Mato; Jacobo Limeres; Inmaculada Tomás; Maria Muñoz; Concepción Abuín; Javier F Feijoo; Pedro Diz
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

Review 3.  Gastrointestinal Dysfunction in Parkinson's Disease.

Authors:  Delaram Safarpour; Kaveh Sharzehi; Ronald F Pfeiffer
Journal:  Drugs       Date:  2022-01-25       Impact factor: 9.546

4.  Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia.

Authors:  Pierangelo Barbero; Marco Busso; Marco Tinivella; Carlo Alberto Artusi; Stefania De Mercanti; Angele Cucci; Andrea Veltri; Paolo Avagnina; Andrea Calvo; Adriano Chio'; Luca Durelli; Marinella Clerico
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

5.  The Effectiveness of Botulinum Toxin Type A Injections in the Management of Sialorrhea.

Authors:  Özgür Sürmelioğlu; Muhammed Dağkıran; Ülkü Tuncer; Süleyman Özdemir; Özgür Tarkan; Fikret Çetik; Mete Kıroğlu
Journal:  Turk Arch Otorhinolaryngol       Date:  2018-06-01

6.  Intraductal Salivary Gland Infusion With Botulinum Toxin.

Authors:  Adam T Schwalje; Henry T Hoffman
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-09-03

7.  Ictal Hypersalivation and Salivary Gland Enlargement in a Patient With Acquired Frontal Lobe Epilepsy.

Authors:  Edward C Mader; Xinran M Xiang; Piotr W Olejniczak; Daniella Miller
Journal:  Cureus       Date:  2021-05-29

Review 8.  Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.

Authors:  Amanda Amrita Lakraj; Narges Moghimi; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2013-05-21       Impact factor: 4.546

9.  Accuracy of Ultrasound-Guided and Non-ultrasound-Guided Botulinum Toxin Injection Into Cadaver Salivary Glands.

Authors:  Jae In So; Dae Heon Song; Joo Hyun Park; Eunseok Choi; Jung Yoon Yoon; Yeonji Yoo; Myung Eun Chung
Journal:  Ann Rehabil Med       Date:  2017-02-28

10.  Botulinum toxin treatment for hypersalivation in anti-NMDA receptor encephalitis.

Authors:  Jin-Sun Jun; Han Gil Seo; Soon-Tae Lee; Kon Chu; Sang Kun Lee
Journal:  Ann Clin Transl Neurol       Date:  2017-09-26       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.